Results of anakinra treatment in rheumatoid arthritis patients previously treated with tumor necrosis factor α blockade: Comment on the article by Buch et al [2]

Arthritis and Rheumatism

Volumn 50, Issue 9, 2004, Pages 3049-3050

  Saxne, Tore ^a   Larsson, Lotta ^a   Geborek, Pierre ^a   Buch, Maya H ^b   Bingham, Sarah J ^b   Seto, Yohei ^b   McGonagle, Dennis ^b   Bejarano, Victoria ^b   White, Jo ^b   Emery, Paul ^b  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; PREDNISOLONE; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ADVERSE DRUG REACTION; DISEASE ACTIVITY; DRUG EFFECT; DRUG EFFICACY; DRUG RESPONSE; HUMAN; LETTER; OUTCOMES RESEARCH; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SCORING SYSTEM; TREATMENT FAILURE;

EID: 4444268519     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.20640     Document Type: Letter

References (0)